Chronic pain patients received medically unnecessary injections from Pain MD as part of a decade-long fraud scheme.

Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.